Literature DB >> 15365056

Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2.

François Trueba1, Michel Fabre, Patrick Saint-Blancard.   

Abstract

We report a rare mesenteric localized Mycobacterium genavense infection in a severely immunocompromised human immunodeficiency virus-infected patient. An INNO-LiPA MYCOBACTERIA v2 test was performed directly on biopsy samples. This new molecular tool could be used for simultaneous identification of mycobacterium species from human specimens, but other studies are needed to validate our first results.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365056      PMCID： PMC516359          DOI： 10.1128/JCM.42.9.4403-4404.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification.

Authors:  Enrico Tortoli; Alessandro Mariottini; Gianna Mazzarelli
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Performance assessment of new multiplex probe assay for identification of mycobacteria.

Authors:  E Tortoli; A Nanetti; C Piersimoni; P Cichero; C Farina; G Mucignat; C Scarparo; L Bartolini; R Valentini; D Nista; G Gesu; C P Tosi; M Crovatto; G Brusarosco
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory.

Authors:  Cathal E O'Sullivan; David R Miller; Peggy S Schneider; Glenn D Roberts
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.

Authors:  V O Thomsen; U B Dragsted; J Bauer; K Fuursted; J Lundgren
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Mycobacterium genavense infection in AIDS: imaging findings in eight patients.

Authors:  J M Monill; T Franquet; M A Sambeat; A Martínez-Noguera; J Villalba
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

6.  Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures.

Authors:  L Realini; P Van Der Stuyft; K De Ridder; B Hirschel; F Portaels
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Assessment of the Mycobacteria Growth Indicator Tube for the bacteriological diagnosis of tuberculosis.

Authors:  O Diraa; K Fdany; M Boudouma; N Elmdaghri; M Benbachir
Journal:  Int J Tuberc Lung Dis       Date:  2003-10       Impact factor: 2.373

8.  Disseminated "Mycobacterium genavense" infection in patients with AIDS.

Authors:  E C Böttger; A Teske; P Kirschner; S Bost; H R Chang; V Beer; B Hirschel
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321
  8 in total
  3 in total

1.  Evaluation of the invader assay with the BACTEC MGIT 960 system for prompt isolation and identification of mycobacterial species from clinical specimens.

Authors:  Sadahiro Ichimura; Makoto Nagano; Nobuko Ito; Masahiro Shimojima; Toru Egashira; Chikara Miyamoto; Kiyofumi Ohkusu; Takayuki Ezaki
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

2.  Tuberculosis in Birds: Insights into the Mycobacterium avium Infections.

Authors:  Kuldeep Dhama; Mahesh Mahendran; Ruchi Tiwari; Shambhu Dayal Singh; Deepak Kumar; Shoorvir Singh; Pradeep Mahadev Sawant
Journal:  Vet Med Int       Date:  2011-07-04

3.  Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.

Authors:  Blandine Rammaert; Louis-Jean Couderc; Elisabeth Rivaud; Patrick Honderlick; David Zucman; Marie-France Mamzer; Pierre Cahen; Emmanuel Bille; Marc Lecuit; Olivier Lortholary; Emilie Catherinot
Journal:  BMC Infect Dis       Date:  2011-11-05       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.